Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $45.1 million.

  • Rallybio's Shares Outstanding (Weighted Average) rose 104.36% to $45.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.1 million, marking a year-over-year increase of 104.36%. This contributed to the annual value of $43.5 million for FY2024, which is 765.79% up from last year.
  • According to the latest figures from Q3 2025, Rallybio's Shares Outstanding (Weighted Average) is $45.1 million, which was up 104.36% from $44.8 million recorded in Q2 2025.
  • Rallybio's 5-year Shares Outstanding (Weighted Average) high stood at $45.1 million for Q3 2025, and its period low was $40.2 million during Q1 2023.
  • Over the past 3 years, Rallybio's median Shares Outstanding (Weighted Average) value was $43.5 million (recorded in 2024), while the average stood at $42.7 million.
  • Per our database at Business Quant, Rallybio's Shares Outstanding (Weighted Average) skyrocketed by 1002.12% in 2024 and then soared by 104.36% in 2025.
  • Rallybio's Shares Outstanding (Weighted Average) (Quarter) stood at $40.4 million in 2023, then grew by 7.66% to $43.5 million in 2024, then increased by 3.48% to $45.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $45.1 million in Q3 2025, compared to $44.8 million in Q2 2025 and $44.8 million in Q1 2025.